Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Filings indexed 1,740 across all filing types
Latest filing 2022-06-14 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
111年6月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, capital increases, capital reductions, and dates of regulatory approvals related to capital changes. It does not contain financial statements or performance data but focuses on capital changes and share capital details. The document length is short (861 characters) and appears to be a regulatory announcement of capital changes rather than a full financial report. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2022-06-14 Chinese
111年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, supervisors, general managers, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider shareholding disclosures, showing changes in ownership and holdings by company insiders. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is a regulatory disclosure of insider share transactions or holdings. According to the filing definitions, reports of personal share transactions by company directors and executives (insider trades) fall under Director's Dealing (DIRS). Therefore, this document is best classified as a Director's Dealing report.
2022-06-10 Chinese
111年05月董事會成員及持股
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on the personal shareholdings and pledges of insiders rather than financial results, governance policies, or meeting materials. The content matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document is about insider shareholdings and pledges, not an announcement of a report or a general regulatory filing. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-06-10 Chinese
111年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (華廣) providing information about fund loans and endorsement guarantees for the current and previous month, including limits and balances. It contains tabulated financial data but is very short (601 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial status related to guarantees and loans rather than a full financial report or announcement of a report. There is no indication of an annual or interim report, audit report, or earnings release. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement or compliance disclosure.
2022-06-09 Chinese
111年5月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 華廣, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The document length is short (766 characters), and it does not present itself as a full financial report but rather as a brief revenue summary. It lacks any indication of being an annual or interim report, audit report, or earnings release. It also does not announce any voting results, management changes, or legal proceedings. Given the nature and length, this document fits best as a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2022-06-09 Chinese
111年05月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including detailed numbers of shares held before and after changes, and related regulatory references. It does not contain financial statements, management discussion, or report content. It is a regulatory disclosure about shareholding changes and holdings, typical of a Major Shareholding Notification. The document length is short (1205 characters), and it is not an announcement of a report publication but a direct disclosure of shareholding data. Therefore, it fits best under Major Shareholding Notification (MRQ).
2022-05-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.